Browse > Article

A Case Report and Literature Review : Treatment of Nasopharyngeal Cancer(NPC) Patient with AOSD(Adult Onset Still's Disease)  

Kim, Jun Young (Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine)
Kim, Jin Dong (Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine)
Lee, Kyung Bin (Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine)
Lee, Won Jae (Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine)
Na, Gun Wung (Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine)
Park, Wonil (Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine)
Park, Gi Cheol (Department of Otolaryngology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine)
Kim, Tae Gyu (Department of Radiation Oncology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine)
Ji, Jun Ho (Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine)
Publication Information
Korean Journal of Head & Neck Oncology / v.30, no.1, 2014 , pp. 15-19 More about this Journal
Keywords
비인두암;성인형 스틸씨병;항암화학방사선 동시치료;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Bosch-Barrera J, Montero A, Lopez-Picazo JM, Garcia-Foncillas J, Ferrer M, Yuste JR, et al. Adult onset Still's disease after first cycle of pemetrexed and gemcitabine for non-small cell lung cancer. Lung Cancer. 2009;64:124-126.   DOI
2 Afqir S, Ismaili N, Errihani H. Concurrent chemoradiotherapy in the management of advanced nasopharyngeal carcinoma: Current status. Journal of Cancer Research and Therapeutics. 2009;5:3-7.   DOI
3 Chan AT, Teo PM, Johnson PJ. Nasopharyngeal Carcinoma. 2002; 13:1007-1015.
4 Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA: A Cancer Journal for Clinicians. 2013;63:11-30.   DOI   ScienceOn
5 Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: A Cancer Journal for Clinicians. 2011; 61:69-90.   DOI
6 Kim TH, Ko YH, Lee MA, Kim BS, Chung SR, Yoo IeR, et al. Treatment outcome of cisplatin-based concurrent chemoradiotherapy in the patients with locally advanced nasopharyngeal cancer. Cancer research and treatment: Official Journal of Korean Cancer Association. 2008;40:62-70.   DOI
7 Chu ST, Wu PH, Hou YY, Chang KP, Chi CC, Lee CC. Primary tumor volume of nasopharyngeal carcinoma: Significance for recurrence and survival. Journal of the Chinese Medical Association: JCMA. 2008,71:461-466.
8 Mayr NA, Riggs CE Jr, Saag KG, Wen BC, Pennington EC, Hussey DH. Mixed connective tissue disease and radiation toxicity. A case report. Cancer. 1997;79:612-618.   DOI
9 Chen A, Obedian E, Haffty B. Breast-conserving therapy in the setting of collagen vascular disease. Cancer J. 2001;7(6):480- 491.
10 Teo P, Tai TH, Choy D. Nasophayngeal carcinoma with dermatomyositis. International Journal of Radiation oncology, Biology, Physics. 1989;16:471-474.   DOI
11 Varga J, Haustein UF, Creech RH, Dwyer JP, Jimenez SA. Exaggerated radiation-induced fibrosis in patients with systemic sclerosis. JAMA: The Journal of the American Medical Association. 1991;265:3292-3295.   DOI
12 Chen AP, Setser A, Anadkat MJ, Cotliar J, Olsen EA, Garden BC, et al. Common Terminology Criteria for Adverse Events(CTCAE). J Am Acad Dermatol. 2012;67:1025-1039.   DOI   ScienceOn
13 Chen WC, Lai CH, Lee TF, Hung CH, Liu KC, Tsai MF, et al. Scintigraphic assessment of salivary function after intensitymodulated radiotherapy for head and neck cancer: Correlations with parotid dose and quality of life. Oral Oncology. 2013;49:42-48.   DOI   ScienceOn
14 Jha N, Harris J, Seikaly H, Jacobs JR, McEwan AJ, Robbins KT, et al. A phase II study of submandibular gland transfer prior to radiation for prevention of radiation-induced xerostomia in headand-neck cancer(RTOG 0244). International Journal of Radiation Oncology, Biology, Physics. 2012;84:437-442.   DOI
15 Hadley T, Song C, Wells L, Lehnhardt J, Rogers MW, Anderson J, et al. Does hyperbaric oxygen therapy have the potential to improve salivary gland function in irradiated head and neck cancer patients? Medical Gas Research. 2013;3:15.   DOI
16 LeVeque FG, Montgomery M, Potter D, Zimmer MB, Rieke JW, Steiger BW, et al. A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients. Journal of clinical oncology: Official Journal of the American Society of Clinical Oncology. 1993;11:1124-1131.   DOI
17 Johnson JT, Ferretti GA, Nethery WJ, Valdez IH, Fox PC, Ng D, et al. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. The New England Journal of Medicine. 1993;329:390-395.   DOI
18 Chan AT, Leung SF, Ngan RK, Teo PM, Lau WH, Kwan WH, et al. Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. Journal of the National Cancer In-- 19 - stitute. 2005;97:536-539.   DOI   ScienceOn
19 Chan AT, Teo PM, Ngan RK, Leung TW, Lau WH, Zee B, et al. Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: Progression-free survival analysis of a phase III randomized trial.Journal of clinical oncology: Official Journal of the American Society of Clinical Oncology. 2002;20:2038-2044.   DOI   ScienceOn
20 Abbasi F, Farhadi S, Esmaili M. Efficacy of Pilocarpine and Bromhexine in Improving Radiotherapy-induced Xerostomia. Journal of Dental Research, Dental Clinics, Dental Prospects. 2013;7:86-90.
21 Kakoei S, Haghdoost AA, Rad M, Mohammadalizadeh S, Pourdamghan N, Nakhaei M, et al. Xerostomia after radiotherapy and its effect on quality of life in head and neck cancer patients. Archives of Iranian Medicine. 2012;15:214-218.
22 Kadar J, Petrovicz E. Adult-onset Still's disease. Best Practice & Research Clinical Rheumatology. 2004;18:663-676.   DOI   ScienceOn
23 Neishi J, Tsukada Y, Maehara T, Ueki K, Maezawa A, Nojima Y. Adult Still's disease as a paraneoplastic manifestation of breast cancer. Scandinavian Journal of Rheumatology. 2000;29: 328-330.   DOI
24 Komano Y, Kubota T, Wakabayashi S, Ochi S, Nonomura Y, Hagiyama H, et al. A case of paraneoplastic syndrome mimicking adult-onset Still's disease. Modern rheumatology/the Japan Rheumatism Association. 2004;14:410-413.   DOI
25 Wong P, Tam LS. Lymphoma in a patient with adult onset Still's disease refractory to immunosuppressants. Hong Kong Bull Rheum Dis. 2009;9:58-60.
26 Sono H, Matsuo K, Miyazato H, Sakaguchi M, Matsuda M, Hamada K, et al. A case of adult-onset Still's disease complicated by non-Hodgkin's lymphoma. Lupus. 2000;9:468-470.   DOI
27 Nakagawa Y, Furusyo N, Taniai H, Henzan H, Tsuchihashi T, Hayashi J. Chronic myelogenous leukemia that occurred two years after the diagnosis of adult Still's disease. Internal Medicine. 2005;44:994-997.   DOI
28 Wu N, Li Q, Gu CX, Ahmed T, Yao XP. Paraneoplastic syndrome mimicking adult-onset Still's disease caused by advanced lung cancer: A case report. BMC Cancer. 2011;11:487.   DOI
29 Horiot JC, Lipinski F, Schraub S, Maulard-Durdux C, Bensadoun RJ, Ardiet JM, et al. Post-radiation severe xerostomia relieved by pilocarpine: A prospective French cooperative study. Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology. 2000;55:233-239.   DOI
30 Zhang L, Zhao C, Ghimire B, Hong MH, Liu Q, Zhang Y, et al. The role of concurrent chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma among endemic population: A meta-analysis of the phase III randomized trials. BMC Cancer. 2010;10:558.   DOI   ScienceOn